216 related articles for article (PubMed ID: 18841443)
21. Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis.
Magbanua MJ; Melisko M; Roy R; Sosa EV; Hauranieh L; Kablanian A; Eisenbud LE; Ryazantsev A; Au A; Scott JH; Park JW
Cancer Res; 2013 Dec; 73(23):7134-43. PubMed ID: 24142343
[TBL] [Abstract][Full Text] [Related]
22. Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence.
Marques AR; Teixeira E; Diamond J; Correia H; Santos S; Neto L; Ribeiro M; Miranda A; Passos-Coelho JL
Breast Cancer Res Treat; 2009 Mar; 114(2):223-32. PubMed ID: 18409061
[TBL] [Abstract][Full Text] [Related]
23. Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction.
Grünewald K; Haun M; Fiegl M; Urbanek M; Müller-Holzner E; Massoner A; Riha K; Propst A; Marth C; Gastl G
Lab Invest; 2002 Sep; 82(9):1147-53. PubMed ID: 12218075
[TBL] [Abstract][Full Text] [Related]
24. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
25. Disseminated tumor cells in bone marrow assessed by TWIST1, cytokeratin 19, and mammaglobin A mRNA predict clinical outcome in operable breast cancer patients.
Tjensvoll K; Oltedal S; Farmen RK; Shammas FV; Heikkilä R; Kvaløy JT; Gilje B; Smaaland R; Nordgård O
Clin Breast Cancer; 2010 Oct; 10(5):378-84. PubMed ID: 20920982
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of hMAM mRNA detection in bone marrow of breast carcinoma patient].
Li BJ; Wang JY; Wang HY; Huang XP; Zhang LJ; Long H; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):766-9. PubMed ID: 17366790
[TBL] [Abstract][Full Text] [Related]
27. Detection of circulating tumour cells in breast cancer patients using human mammaglobin RT-PCR: association with clinical prognostic factors.
Ferro P; Franceschini MC; Bacigalupo B; Dessanti P; Falco E; Fontana V; Gianquinto D; Pistillo MP; Fedeli F; Roncella S
Anticancer Res; 2010 Jun; 30(6):2377-82. PubMed ID: 20651396
[TBL] [Abstract][Full Text] [Related]
28. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
Ghaffari SR; Sabokbar T; Tahmasebi S; Dastan J; Shorakae S; Moradi A; Tirgari F; Mohagheghi MA; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2006; 7(3):396-8. PubMed ID: 17059329
[TBL] [Abstract][Full Text] [Related]
29. Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer.
Lee JS; Melisko ME; Magbanua MJ; Kablanian AT; Scott JH; Rugo HS; Park JW
Breast Cancer Res Treat; 2015 Nov; 154(2):339-49. PubMed ID: 26520840
[TBL] [Abstract][Full Text] [Related]
30. Single-cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases.
Ruan H; Wang Z; Sun Z; Wei J; Zhang L; Ju H; Wang T; Zhang C; Guan M; Pan S
Clin Transl Med; 2022 Jun; 12(6):e885. PubMed ID: 35678121
[TBL] [Abstract][Full Text] [Related]
31. Leptomeningeal carcinomatosis: easy to miss.
Sekhar A; Corbo B; Das K; Biswas S
J R Coll Physicians Edinb; 2017 Dec; 47(4):351-352. PubMed ID: 29537406
[TBL] [Abstract][Full Text] [Related]
32. Human mammaglobin: a superior marker for reverse-transcriptase PCR in detecting circulating tumor cells in breast cancer patients.
Li G; Zhang J; Jin K; He K; Wang H; Lu H; Teng L
Biomark Med; 2011 Apr; 5(2):249-60. PubMed ID: 21473729
[TBL] [Abstract][Full Text] [Related]
33. Cerebrospinal fluid cytology and clinical analysis of 34 cases with leptomeningeal carcinomatosis.
Liu J; Jia H; Yang Y; Dai W; Su X; Zhao G
J Int Med Res; 2009; 37(6):1913-20. PubMed ID: 20146891
[TBL] [Abstract][Full Text] [Related]
34. Mammaglobin and maspin transcripts in blood may reflect disease progression and the effect of therapy in breast cancer.
Bitisik O; Saip P; Saglam S; Derin D; Dalay N
Genet Mol Res; 2010; 9(1):97-106. PubMed ID: 20092039
[TBL] [Abstract][Full Text] [Related]
35. SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
Vinayanuwattikun C; Mingmalairak S; Jittapiromsak N; Thaipisuttikul I; Sriuranpong V; Mutirangura A; Shuangshoti S
J Neurooncol; 2016 Sep; 129(3):395-403. PubMed ID: 27401153
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of leptomeningeal carcinomatosis in 4 cases].
Bao J; Hu XQ; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Nov; 28(11):2047-9. PubMed ID: 19033125
[TBL] [Abstract][Full Text] [Related]
37. Novel methods to diagnose leptomeningeal metastases in breast cancer.
Angus L; Martens JWM; van den Bent MJ; Sillevis Smitt PAE; Sleijfer S; Jager A
Neuro Oncol; 2019 Mar; 21(4):428-439. PubMed ID: 30418595
[TBL] [Abstract][Full Text] [Related]
38. Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer.
Fleming TP; Watson MA
Ann N Y Acad Sci; 2000; 923():78-89. PubMed ID: 11193781
[TBL] [Abstract][Full Text] [Related]
39. Rare case of pancreatic cancer with leptomeningeal carcinomatosis.
Yoo IK; Lee HS; Kim CD; Chun HJ; Jeen YT; Keum B; Kim ES; Choi HS; Lee JM; Kim SH; Nam SJ; Hyun JJ
World J Gastroenterol; 2015 Jan; 21(3):1020-3. PubMed ID: 25624740
[TBL] [Abstract][Full Text] [Related]
40. [Diagnostic Value of Locally Produced Tumor Markers and Blood Brain Barrier
Integrity in Lung Cancer Patients with Leptomeningeal Metastasis].
Lin Y; Yu T; Li H; Yin Z; Guo A
Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):567-576. PubMed ID: 34120432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
